Nov 1, 2022
Kent speaks with Michael Curtis, Ph.D., President & CEO of eGenesis.
Dr. Curtis has more than 30 years of experience in scientific research and leadership in biopharmaceutical drug development across multiple therapeutic areas. Before joining eGenesis he served as Chief Executive Officer, President and Head of R&D at Cadent Therapeutics. Moreover, Dr. Curtis was an Entrepreneur-in-Residence at Atlas Venture where he played a role in the creation of several companies including Delinia and Q32 Bio. Dr. Curtis has led the development of multiple products from discovery through first-in-human, Phase 2 and 3 studies. He was involved in the early development of Orencia and Nulojix.
Dr. Curtis earned a Ph.D. in Cell and Molecular Biology from the State University of New York Upstate Medical University.
If you have questions regarding items discussed during this episode or would like more information about Kidney Solutions weekly Support Group, contact Kent at firstname.lastname@example.org
For more information about Kidney Solutions, visit them at www.kidneysolutions.org
Host: Kent Bressler
Producer: Jason Nunez